In our study, the level of PSGL-1 was found to increase in IMV patients and was the only coagulation protein that showed a significant increase in the second determination of coagulation proteins in plasma levels, which could indicate the relevance of this glycoprotein in the late stage of COVID-19. The gene discussed is SELPLG; the disease is COVID-19.